Literature DB >> 33190227

Establishing criteria for pediatric epilepsy surgery center levels of care: Report from the ILAE Pediatric Epilepsy Surgery Task Force.

William D Gaillard1, Nathalie Jette2, Susan T Arnold3, Alexis Arzimanoglou4,5, Kees P J Braun6, Arthur Cukiert7, Alexander Dick1, A Simon Harvey8, Julia Jacobs9, Bertil Rydenhag10, Vrajesh Udani11, Jo M Wilmshurst12, J Helen Cross13, Prasanna Jayakar14.   

Abstract

Presurgical evaluation and surgery in the pediatric age group are unique in challenges related to caring for the very young, range of etiologies, choice of appropriate investigations, and surgical procedures. Accepted standards that define the criteria for levels of presurgical evaluation and epilepsy surgery care do not exist. Through a modified Delphi process involving 61 centers with experience in pediatric epilepsy surgery across 20 countries, including low-middle- to high-income countries, we established consensus for two levels of care. Levels were based on age, etiology, complexity of presurgical evaluation, and surgical procedure. Competencies were assigned to the levels of care relating to personnel, technology, and facilities. Criteria were established when consensus was reached (≥75% agreement). Level 1 care consists of children age 9 years and older, with discrete lesions including hippocampal sclerosis, undergoing lobectomy or lesionectomy, preferably on the cerebral convexity and not close to eloquent cortex, by a team including a pediatric epileptologist, pediatric neurosurgeon, and pediatric neuroradiologist with access to video-electroencephalography and 1.5-T magnetic resonance imaging (MRI). Level 2 care, also encompassing Level 1 care, occurs across the age span and range of etiologies (including tuberous sclerosis complex, Sturge-Weber syndrome, hypothalamic hamartoma) associated with MRI lesions that may be ill-defined, multilobar, hemispheric, or multifocal, and includes children with normal MRI or foci in/abutting eloquent cortex. Available Level 2 technologies includes 3-T MRI, other advanced magnetic resonance technology including functional MRI and diffusion tensor imaging (tractography), positron emission tomography and/or single photon emission computed tomography, source localization with electroencephalography or magnetoencephalography, and the ability to perform intra- or extraoperative invasive monitoring and functional mapping, by a large multidisciplinary team with pediatric expertise in epilepsy, neurophysiology, neuroradiology, epilepsy neurosurgery, neuropsychology, anesthesia, neurocritical care, psychiatry, and nursing. Levels of care will improve safety and outcomes for pediatric epilepsy surgery and provide standards for personnel and technology to achieve these levels.
© 2020 International League Against Epilepsy.

Entities:  

Keywords:  care; children; epilepsy; surgery

Year:  2020        PMID: 33190227     DOI: 10.1111/epi.16698

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  4 in total

Review 1.  Pharmacotherapy for Seizures in Tuberous Sclerosis Complex.

Authors:  Rima Nabbout; Mathieu Kuchenbuch; Catherine Chiron; Paolo Curatolo
Journal:  CNS Drugs       Date:  2021-08-21       Impact factor: 5.749

2.  United States Epilepsy Center Characteristics: A Data Analysis From the National Association of Epilepsy Centers.

Authors:  Adam P Ostendorf; Stephanie M Ahrens; Fred Alexander Lado; Susan T Arnold; Shasha Bai; Meriem K Bensalem Owen; Kevin E Chapman; Dave F Clarke; Mariah Eisner; Nathan B Fountain; Johanna M Gray; Jennifer L Hopp; Ellen Riker; Stephan U Schuele; Barbara V Small; Susan T Herman
Journal:  Neurology       Date:  2021-12-08       Impact factor: 11.800

Review 3.  Underutilization of epilepsy surgery: Part II: Strategies to overcome barriers.

Authors:  Debopam Samanta; Rani Singh; Satyanarayana Gedela; M Scott Perry; Ravindra Arya
Journal:  Epilepsy Behav       Date:  2021-03-04       Impact factor: 2.937

4.  Clinical Utility of Transcranial Magnetic Stimulation (TMS) in the Presurgical Evaluation of Motor, Speech, and Language Functions in Young Children With Refractory Epilepsy or Brain Tumor: Preliminary Evidence.

Authors:  Shalini Narayana; Savannah K Gibbs; Stephen P Fulton; Amy Lee McGregor; Basanagoud Mudigoudar; Sarah E Weatherspoon; Frederick A Boop; James W Wheless
Journal:  Front Neurol       Date:  2021-05-19       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.